eRaDicate

The project “eRaDicate” is a Horizon-Europe Marie Sklodowska-Curie Doctoral-Network offering an international PhD programme in the cancer field. The scientific aims of eRaDicate are for the PhD candidates to test novel  drugs as anti-cancer agents, such as the retinoic acid receptor (RAR) and the vitamin D receptor (VDR) using a variety of molecular biology and biochemical methods, as well as bioinformatics approaches. The project was launched at the kick-off meeting at TissueGnostics in Vienna from the 7-9.2.2024.